Currently predicting for Thu, 4 Jun 2026

LLY Prediction Chart

LLY Predictions History

Latest community submissions for LLY.
Predictor Target Session Target Price Result Direction Accuracy Score
Nov 4, 2025 Bearish $906.86 X 0
Nov 3, 2025 $853.90 -1.04% $896.53 X 95.24% 0
Nov 3, 2025 $857.26 -0.65% $896.53 X 95.62% 0
Nov 3, 2025 Bullish $896.53 V 1
Rt Rt
Oct 20, 2025 Bullish $808.96 V 1
Oct 2, 2025 Bullish $819.85 X 0
Sep 16, 2025 $755.45 +0.97% $764.71 V 98.79% 2
Sep 16, 2025 $743.66 -0.61% $764.71 X 97.25% 0
Sep 16, 2025 Bullish $764.71 V 1
Sep 15, 2025 $748.01 -0.98% $748.19 V 99.98% 10
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LLY with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ELI LILLY AND COMPANY
Eli Lilly
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE